Knockdown of the long isoform of the prolactin receptor selectively targets pathogenic immune cells in systemic lupus erythematosus and averts glomerular pathology
Systemic lupus erythematosus (SLE) is a complex autoimmune disease marked by chronic inflammation and immune activation across multiple tissues. Current treatments often fail to sustain remission owing to their inability to selectively target pathogenic immune cells.